Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
PURITAN MEDICAL
Demo Company

Membrane Chromatography Issues Addressed by New Smartphone Application

By BiotechDaily International staff writers
Posted on 31 Jul 2013
Image: Example of a Sartobind App screen (Photo courtesy of Sartorius Stedim Biotech).
Image: Example of a Sartobind App screen (Photo courtesy of Sartorius Stedim Biotech).
A new smartphone application will benefit biotech researchers and other life scientists who employ membrane chromatographic techniques, whether they are novices or expert practitioners.

Sartorius Stedim Biotech (Aubagne, France) recently introduced the Sartobind App to complement its Sartobind membrane adsorber portfolio. The application (app) was optimized for Apple iPhones but will run on many android smartphones as well.

The company will use the app to provide mobile phone users with a selection of training tools to complement its chromatography product portfolio and provide links to all the literature available in its digital library.

The app features a product finder that enables both novices and experts to select the appropriate membranes required for various chromatography processes and procedures. Beginning chromatographers will benefit from the app's Ion Exchange Calculator, which clarifies the interplay between pH and the isoelectric point of the protein of interest.

A flexible search function for downloading application notes and other literature according to search parameters related to target molecule, membrane type, device format, and scale will be appreciated by more experienced users. Other valuable features for all users are a flow rate calculator, an isoelectric point list for proteins and viruses, a comprehensive chromatography glossary, and a FAQ document.

The chromatography app can be downloaded free-of-charge online (please see Related Links below.

Related Links:
Sartorius Stedim Biotech
Chromatography app



Channels

Genomics/Proteomics

view channel
Image: An activated PTEN dimer that contains two non-mutant proteins (A) can transform the functional lipid (D) on the cellular membrane (E) into a chemical form that tunes down cancer predilection. Dimers that contain a mutated protein (B) or PTEN monomers cannot transform the functional lipid (Photo courtesy of Carnegie Mellon University).

PTEN Requires a Stable Dimer Configuration to Effectively Suppress Tumor Growth

Molecular structural analysis has shown that the PTEN (phosphatase and tensin homolog) tumor suppressor can function effectively only when two wild-type alleles are present to form a stable dimer that... Read more

Business

view channel

MS Drug Deal to Net More Than USD 1 Billion

A pharmaceutical company based in Switzerland has purchased the remaining rights to the multiple sclerosis drug Ofatumumab, which will allow it to continue development of the compound for treating relapsing remitting multiple sclerosis (RRMS) and similar autoimmune diseases. Novartis (Basel, Switzerland) recently announced... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.